TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
PYXS

Pyxis Oncology Inc

Healthcare · Biotechnology

2.90$ -9.3% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet PYXS
Line item 2019 2020 2021 2022 2023 2024 2025
– -48.8% +2,658.6% -24.5% -17.8% -9.5% -41.8%
– -58.9% +3,339.1% -33.0% -33.2% +6.3% -45.6%
– -59.0% +3,300.2% -34.7% -94.6% +101.5% -20.8%
– -59.0% +3,300.2% -34.7% -33.5% +6.4% -47.3%
– – – – -96.5% – –
– – – – – – –
– +2,451.3% -48.1% +1,008.7% – – –
– – – – – -89.3% –
– +13.7% -27.5% +170.2% -5.0% -24.1% +4.6%
– +403.3% +407.1% +69.1% -18.6% -31.4% +19.5%
– +6,733.3% -73.2% – – +17.7% +16.7%
– +119.3% +1,009.7% -40.6% -45.1% +24.7% +124.0%
– – – -38.5% -21.8% -3.9% -55.8%
– – – – – – –
– +0.0% -6.1% +2.5% +20.8% +46.5% +6.3%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?